News 01 Mar 2024 Idorsia enters collaboration with Viatris The biotech company Idorsia from the canton of Basel-Landschaft and the North American pharmaceutical company Viatris are collaborating on the de...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 Ott 2024–24 Ott 2024 Malham Arabia Saudita
News 18 Ott 2022 KetoSwiss secures capital increase of 4 million dollars KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based start-up develops products to alleviate neurological disease...
News 17 Ott 2022 Escientia Switzerland becomes Primopus The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The Swiss subsidiary of America’s Esc...
News 26 Ott 2022 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...
News 11 Dic 2019 French company La Salle Blanche opens a subsidiary in Valais For more than 30 years, LSB has been active in the health, pharma and research sectors. The company will now be able to meet the needs of the Swi...
Actualités 10 Mag 2022 La Fondation Michael J. Fox accorde une bourse à Asceneuron pour traiter la maladie de Parkinson Déterminée à accélérer la recherche de nouvelles thérapies pour la maladie de Parkinson, la Michael J. Fox Foundation for Parkinson's Research oc...
News 08 Mar 2024 VirtaMed and Atracsys announce collaboration VirtaMed and Atracsys are joining forces to drive innovation in medical training and simulation. The partners are focusing on robot-assisted and ...
Aktuell 05 Set 2023 Mabylon entwickelt Wirkstoff gegen Erdnussallergie mit Pfizer weiter Das Biotech-Unternehmen Mabylon hat eine Kooperation mit dem Biotech-Förderer Pfizer Ignite vereinbart. Mabylon will dadurch die Entwicklung sein...
News 19 Giu 2023 Revolutionary breakthrough in prostate cancer treatment at the University of Bern In an exciting turn of events in the world of cancer therapy, researchers from the University of Bern, Inselspital Bern, and the University of Co...
Aktuell 08 Feb 2022 AMR Action Fund eröffnet Europasitz in Basel Der AMR Action Fund hat seine neue Europa-Niederlassung in Basel bezogen. Der Risikokapitalfonds ist die grösste öffentlich-private Partnerschaft...
News 09 Gen 2023 AMR Action Fund invests in new antibiotics developed by BioVersys The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The world’s second largest fo...
News 09 Giu 2023 UZH takes on pioneering role for One Health Three faculties at the University of Zurich (UZH) have founded the first One Health Institute at a European university. The disciplines of veteri...
News 19 Feb 2024 Solita opens new office in Zurich under its Intellishore brand Solita, the Finnish data analysis and strategic consulting firm, is opening an office in Zurich under its Danish brand Intellishore. Intellishore...
News 13 Set 2022 BioLingus develops COVID-19 pills with partners Together with its South Korean partners, CHA Vaccine Institute and PanGen Biotech, BioLingus from the canton of Nidwalden is working on a tablet ...
News 15 Mar 2024 CSS expands headquarters with Diener und Diener Architekten Diener und Diener Architekten have won the CSS Group's architecture competition. The Basel-based architectural firm will expand the headquarters ...
News 19 Ott 2022 Nahtlos banks 1 million Swiss francs from investors The start-up Nahtlos has raised 1 million Swiss francs from investors as part of a financing round. With this fresh capital, the spin-off from th...